speb/financial-data huggingface dataset:
Financial ratios for AVAP.L — annual report dated 2024-06-30
Total revenue: 65795588.23529411
Gross profit: -2819117.647058823
Operating income: -7755882.352941176
Net income: 14511029.411764706
Capital expenditures: 8811764.705882352
Operating cash flow: 59977205.88235293
Depreciation & amortization: 29595588.235294115
Net tangible assets: 104197058.8235294
Owner earnings: 35294852.941176474
Return on net tangible assets (%): 33.87317582634714
Buffett classification: The Gruesome
Stock price: 0.017594936708860757
P/E ratio: 0.07253947013780696
Shares outstanding: 59825301
Book value: 188527205.88235283
P/B ratio: 0.005583397790027265
Market cap (USD): 1052622.384683544
Debt to equity: 2.6346018089135224
Current ratio: 1.3935261614539751
Quick ratio: 1.3935261614539751
Effective tax rate (%): 34.31738001730679
COGS to revenue (%): 104.28466060213226
SG&A to revenue (%): 6.209069980554748
Free cash flow (dilution-adjusted): 59433088.23529412
Buyback yield (%): 6.636087375005889
Retained earnings: 81576470.58823529
Receivables turnover: 10.693355640535373
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0447039807302232
FCF margin (%): 90.32989875058672
Revenue growth (%): -5.293015674777473
Rule of 40 score: 85.03688307580924
Financial ratios for AVAP.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 105355882.35294117
Buffett classification: The Gruesome
Stock price: 0.018875
Shares outstanding: 59825301
Book value: 180627205.88235295
P/B ratio: 0.006251564103308325
Market cap (USD): 1129202.556375
Debt to equity: 2.598958693767224
Current ratio: 1.4737438609746882
Quick ratio: 1.4737438609746882
Buyback yield (%): 0
Retained earnings: 81883823.52941176
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVAP.L — annual report dated 2025-06-30
Total revenue: 88714062.5
Gross profit: 21282812.5
Operating income: 16263281.25
Net income: -6028125
Capital expenditures: 18510156.25
Operating cash flow: 71486718.75
Depreciation & amortization: 31981250
Net tangible assets: 117341406.25
Owner earnings: 7442968.75
Capex to operating income (%): 113.81563145506077
Buffett classification: The Gruesome
Stock price: 0.021232876712328767
Shares outstanding: 59825301
Book value: 190504687.5
P/B ratio: 0.0066678844341347705
Market cap (USD): 1270263.2404109589
Debt to equity: 2.679260680921565
Current ratio: 1.294916533056682
Quick ratio: 1.294916533056682
COGS to revenue (%): 76.00965179562147
SG&A to revenue (%): 4.774820790108671
Free cash flow (dilution-adjusted): 21752343.75
Buyback yield (%): 984.2325080551973
Retained earnings: 80326562.5
Receivables turnover: 18.07609041706463
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2848681950342504
FCF margin (%): 24.519611814643252
Revenue growth (%): 34.83284347690039
Rule of 40 score: 59.35245529154365
Financial ratios for AVAP.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 117341406.25
Buffett classification: The Gruesome
Stock price: 0.021232876712328767
Shares outstanding: 59825301
Book value: 190504687.5
P/B ratio: 0.0066678844341347705
Market cap (USD): 1270263.2404109589
Debt to equity: 2.679260680921565
Current ratio: 1.294916533056682
Quick ratio: 1.294916533056682
Buyback yield (%): 0
Retained earnings: 80326562.5
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDX — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 173.37
Shares outstanding: 275540427
Market cap (USD): 47770443828.99
Buyback yield (%): 3.6633530269567935
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDX — annual report dated 2022-09-30
Total revenue: 18870000000
Gross profit: 8477000000
Operating income: 2475000000
Net income: 1779000000
Capital expenditures: 973000000
Operating cash flow: 2633000000
Depreciation & amortization: 2229000000
Net tangible assets: -11648000000
Owner earnings: 3035000000
Return on net tangible assets (%): -26.055975274725274
Capex to operating income (%): 39.31313131313131
Buffett classification: The Good
Stock price: 163.29
P/E ratio: 25.291172751450254
Shares outstanding: 275540427
Book value: 25282000000
P/B ratio: 1.7796454522913534
Market cap (USD): 44992996324.829994
Debt to equity: 0.6354323233921367
Current ratio: 1.0422481116374345
Quick ratio: 0.6294968633977723
Effective tax rate (%): 8.300616937745373
Interest coverage ratio: 6.21859296482412
COGS to revenue (%): 55.07684154742978
R&D to revenue (%): 6.656067832538421
SG&A to revenue (%): 24.954954954954957
Free cash flow (dilution-adjusted): 1427000000
Buyback yield (%): 1.1112840682807965
Retained earnings: 15157000000
Inventory turnover: 3.2236352357320097
Receivables turnover: 8.612505705157462
Capitalized R&D asset: 1256000000
ROCI (R&D-adjusted, %): 7.141881742455277
FCF margin (%): 7.562268150503444
Rule of 40 score: 7.562268150503444
Financial ratios for BDX — annual report dated 2023-09-30
Total revenue: 19372000000
Gross profit: 8170000000
Operating income: 2424000000
Net income: 1484000000
Capital expenditures: 874000000
Operating cash flow: 2989000000
Depreciation & amortization: 2288000000
Net tangible assets: -9672000000
Owner earnings: 2898000000
Return on net tangible assets (%): -29.962779156327546
Capex to operating income (%): 36.056105610561055
Buffett classification: The Good
Stock price: 192.24
P/E ratio: 35.69399709331537
Shares outstanding: 275540427
Book value: 25797000000
P/B ratio: 2.0533353369182463
Market cap (USD): 52969891686.48
Debt to equity: 0.6155366903128271
Current ratio: 1.306429754555037
Quick ratio: 0.8135822918235206
Effective tax rate (%): 7.9422382671480145
Interest coverage ratio: 5.3628318584070795
COGS to revenue (%): 57.82572785463556
R&D to revenue (%): 6.385504852364238
SG&A to revenue (%): 24.359900887879412
Free cash flow (dilution-adjusted): 1856000000
Buyback yield (%): 0
Retained earnings: 15535000000
Inventory turnover: 3.4225481209899176
Receivables turnover: 7.644830307813733
Capitalized R&D asset: 2078520000
ROCI (R&D-adjusted, %): 5.869235912589449
Rosenberg metric: -0.2444267515923567
FCF margin (%): 9.580838323353294
Revenue growth (%): 2.660307366189719
Rule of 40 score: 12.241145689543014
Financial ratios for BDX — annual report dated 2024-09-30
Total revenue: 20178000000
Gross profit: 9125000000
Operating income: 2856000000
Net income: 1705000000
Capital expenditures: 725000000
Operating cash flow: 3797000000
Depreciation & amortization: 2286000000
Net tangible assets: -11493000000
Owner earnings: 3266000000
Return on net tangible assets (%): -28.417297485425912
Capex to operating income (%): 25.385154061624647
Buffett classification: The Good
Stock price: 182.2
P/E ratio: 29.44484797618768
Shares outstanding: 275540427
Book value: 25889000000
P/B ratio: 1.9391813434045346
Market cap (USD): 50203465799.399994
Debt to equity: 0.7767777820696049
Current ratio: 1.168825368468066
Quick ratio: 0.7397275569450648
Effective tax rate (%): 14.962593516209477
Interest coverage ratio: 5.409090909090909
COGS to revenue (%): 54.7774804242244
R&D to revenue (%): 5.897512141936763
SG&A to revenue (%): 24.07077014570324
Free cash flow (dilution-adjusted): 2825000000
Buyback yield (%): 0
Retained earnings: 16139000000
Inventory turnover: 2.8761384335154827
Receivables turnover: 6.652818991097923
Capitalized R&D asset: 2433270000
ROCI (R&D-adjusted, %): 5.551914471493529
Rosenberg metric: 0.7720291026677445
FCF margin (%): 14.0003964714045
Revenue growth (%): 4.160644228783812
Rule of 40 score: 18.161040700188313
Financial ratios for BDX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 182.2
Shares outstanding: 275540427
Market cap (USD): 50203465799.399994
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 172.26
Shares outstanding: 275540427
Market cap (USD): 47464593955.02
Buyback yield (%): 1.5801251785925743
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDX — quarterly report dated 2025-03-31
Total revenue: 4480000000
Gross profit: 1861000000
Operating income: 477000000
Net income: 308000000
Capital expenditures: 114000000
Operating cash flow: 163000000
Depreciation & amortization: 524000000
Net tangible assets: -11336000000
Owner earnings: 718000000
Return on net tangible assets (%): -6.333803810868031
Capex to operating income (%): 23.89937106918239
Buffett classification: The Great
Stock price: 174.71
P/E ratio: 39.07440584510552
Shares outstanding: 275540427
Book value: 25241000000
P/B ratio: 1.9072012995194327
Market cap (USD): 48139668001.170006
Debt to equity: 0.7634404342141754
Current ratio: 1.1267715511636978
Quick ratio: 0.6426992588740086
Effective tax rate (%): 21.393034825870647
Interest coverage ratio: 3.18
COGS to revenue (%): 58.45982142857142
R&D to revenue (%): 5.178571428571429
SG&A to revenue (%): 24.933035714285715
Free cash flow (dilution-adjusted): 8000000
Buyback yield (%): 0
Retained earnings: 16150000000
Inventory turnover: 0.7034649476228848
Receivables turnover: 1.4790359854737538
Capitalized R&D asset: 232000000
ROCI (R&D-adjusted, %): 1.3437429090083957
FCF margin (%): 0.17857142857142858
Rule of 40 score: 0.17857142857142858
Financial ratios for BDX — quarterly report dated 2025-06-30
Total revenue: 5509000000
Gross profit: 2634000000
Operating income: 979000000
Net income: 574000000
Capital expenditures: 189000000
Operating cash flow: 1220000000
Depreciation & amortization: 702000000
Net tangible assets: -10912000000
Owner earnings: 1087000000
Return on net tangible assets (%): -9.961510263929618
Capex to operating income (%): 19.30541368743616
Buffett classification: The Great
Stock price: 132.17
P/E ratio: 41.29045151540816
Shares outstanding: 275540427
Book value: 25473000000
P/B ratio: 1.429677628728065
Market cap (USD): 36418178236.59
Debt to equity: 0.7592745259686727
Current ratio: 1.1025735294117647
Quick ratio: 0.6186274509803922
Effective tax rate (%): 18.349928876244665
Interest coverage ratio: 6.440789473684211
COGS to revenue (%): 52.187329823924486
R&D to revenue (%): 5.391178072245417
SG&A to revenue (%): 23.96079143220185
Free cash flow (dilution-adjusted): 959000000
Buyback yield (%): 0
Retained earnings: 16426000000
Inventory turnover: 0.7280324132691821
Receivables turnover: 1.871899422358138
Capitalized R&D asset: 452440000
ROCI (R&D-adjusted, %): 2.3300767350278266
Rosenberg metric: 3.331896551724138
FCF margin (%): 17.407878017789074
Revenue growth (%): 22.96875
Rule of 40 score: 40.37662801778907
Financial ratios for BDX — annual report dated 2025-09-30
Total revenue: 21840000000
Gross profit: 9925000000
Operating income: 2986000000
Net income: 1678000000
Capital expenditures: 760000000
Operating cash flow: 3431000000
Depreciation & amortization: 2462000000
Net tangible assets: -10626000000
Owner earnings: 3380000000
Return on net tangible assets (%): -31.808770939205722
Capex to operating income (%): 25.452109845947756
Buffett classification: The Good
Stock price: 144.4
P/E ratio: 23.711583825268175
Shares outstanding: 275540427
Book value: 25390000000
P/B ratio: 1.5670751342575817
Market cap (USD): 39788037658.8
Debt to equity: 0.7554549035053171
Current ratio: 1.113316492241068
Quick ratio: 0.6448935402381811
Effective tax rate (%): 10.792131844763423
Interest coverage ratio: 4.871125611745514
COGS to revenue (%): 54.5558608058608
R&D to revenue (%): 5.792124542124542
SG&A to revenue (%): 24.166666666666668
Free cash flow (dilution-adjusted): 2413000000
Buyback yield (%): 0
Retained earnings: 16622000000
Inventory turnover: 3.0598356445814074
Receivables turnover: 7.294589178356714
Capitalized R&D asset: 2470510000
ROCI (R&D-adjusted, %): 6.1038401918846334
Rosenberg metric: 0.6722689075630253
FCF margin (%): 11.048534798534797
Revenue growth (%): 8.23669342848647
Rule of 40 score: 19.285228227021268
Financial ratios for BDX — quarterly report dated 2025-09-30
Total revenue: 5891000000
Gross profit: 2799000000
Operating income: 826000000
Net income: 493000000
Capital expenditures: 352000000
Operating cash flow: 1355000000
Depreciation & amortization: 629000000
Net tangible assets: -10626000000
Owner earnings: 770000000
Return on net tangible assets (%): -7.246376811594203
Capex to operating income (%): 42.615012106537534
Buffett classification: The Good
Stock price: 144.4
P/E ratio: 28.936754660945454
Shares outstanding: 275540427
Book value: 25390000000
P/B ratio: 1.5670751342575817
Market cap (USD): 39788037658.8
Debt to equity: 0.7554549035053171
Current ratio: 1.113316492241068
Quick ratio: 0.6448935402381811
Effective tax rate (%): 3.3333333333333335
Interest coverage ratio: 5.329032258064516
COGS to revenue (%): 52.48684433882194
R&D to revenue (%): 5.465965031403837
SG&A to revenue (%): 23.187913766762858
Free cash flow (dilution-adjusted): 948000000
Buyback yield (%): 0
Retained earnings: 16622000000
Inventory turnover: 0.7940421160760144
Receivables turnover: 1.9676018704074816
Capitalized R&D asset: 597550000
ROCI (R&D-adjusted, %): 1.8154620939146313
Rosenberg metric: 0.5555555555555556
FCF margin (%): 16.092344253946695
Revenue growth (%): 6.934107823561445
Rule of 40 score: 23.02645207750814
Financial ratios for BDX — quarterly report dated 2025-12-31
Total revenue: 5252000000
Gross profit: 2411000000
Operating income: 662000000
Net income: 382000000
Capital expenditures: 108000000
Operating cash flow: 656000000
Depreciation & amortization: 614000000
Net tangible assets: -10362000000
Owner earnings: 888000000
Return on net tangible assets (%): -8.569774174869718
Capex to operating income (%): 16.314199395770395
Buffett classification: The Great
Stock price: 150.54
P/E ratio: 23.608341423210017
Shares outstanding: 275540427
Book value: 25282000000
P/B ratio: 1.64068728267463
Market cap (USD): 41479855880.579994
Debt to equity: 0.7728423384225932
Current ratio: 1.0488528706768634
Quick ratio: 0.5825818970437164
Effective tax rate (%): 2.7989821882951653
Interest coverage ratio: 4.326797385620915
COGS to revenue (%): 54.09367859862909
R&D to revenue (%): 5.826351865955826
SG&A to revenue (%): 26.523229246001524
Free cash flow (dilution-adjusted): 457000000
Buyback yield (%): 0.6027021904795112
Retained earnings: 16704000000
Inventory turnover: 0.6954712362301102
Receivables turnover: 2.094098883572568
Capitalized R&D asset: 619750000
ROCI (R&D-adjusted, %): 1.4125700173270024
Rosenberg metric: -1.204968944099379
FCF margin (%): 8.701447067783702
Revenue growth (%): -10.847054829400781
Rule of 40 score: -2.145607761617079
Financial ratios for BLIN — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.11
Shares outstanding: 12599879
Market cap (USD): 51785502.690000005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLIN — annual report dated 2022-09-30
Total revenue: 16819000
Gross profit: 11702000
Operating income: -1733000
Net income: 2145000
Capital expenditures: 117000
Operating cash flow: -134000
Depreciation & amortization: 1608000
Net tangible assets: -1901000
Owner earnings: 3636000
Return on net tangible assets (%): -191.26775381378224
Buffett classification: The Gruesome
Stock price: 1.31
P/E ratio: 7.695030997668998
Shares outstanding: 12599879
Book value: 20352000
P/B ratio: 0.8110181549724843
Market cap (USD): 16505841.49
Debt to equity: 0.07891116352201258
Current ratio: 0.8939014202172096
Quick ratio: 0.8939014202172096
Effective tax rate (%): 1.3793103448275863
COGS to revenue (%): 30.423925322551877
R&D to revenue (%): 19.127177596765563
SG&A to revenue (%): 51.24561507818538
Free cash flow (dilution-adjusted): -807000
Buyback yield (%): 0
Retained earnings: -80142000
Receivables turnover: 14.22927241962775
Capitalized R&D asset: 3217000
ROCI (R&D-adjusted, %): 1.586873281422661
FCF margin (%): -4.798144955110292
Rule of 40 score: -4.798144955110292
Financial ratios for BLIN — annual report dated 2023-09-30
Total revenue: 15885000
Gross profit: 10871000
Operating income: -2266000
Net income: -9435000
Capital expenditures: 25000
Operating cash flow: 277000
Depreciation & amortization: 1555000
Net tangible assets: -1898000
Owner earnings: -7905000
Buffett classification: The Gruesome
Stock price: 0.83
Shares outstanding: 12599879
Book value: 11460000
P/B ratio: 0.9125566815008725
Market cap (USD): 10457899.57
Debt to equity: 0.09520069808027923
Current ratio: 0.7704779953674458
Quick ratio: 0.7704779953674458
Interest coverage ratio: -11.989417989417989
COGS to revenue (%): 31.564368901479384
R&D to revenue (%): 23.16021403840101
SG&A to revenue (%): 49.9213094113944
Free cash flow (dilution-adjusted): -319000
Buyback yield (%): 0
Retained earnings: -89577000
Receivables turnover: 15.821713147410359
Capitalized R&D asset: 5834390
ROCI (R&D-adjusted, %): -4.732037891210146
Rosenberg metric: -0.2583152004973578
FCF margin (%): -2.0081838212149825
Revenue growth (%): -5.5532433557286405
Rule of 40 score: -7.5614271769436225
Financial ratios for BLIN — annual report dated 2024-09-30
Total revenue: 15358000
Gross profit: 10434000
Operating income: -1809000
Net income: -1961000
Capital expenditures: 29000
Operating cash flow: -765000
Depreciation & amortization: 1112000
Net tangible assets: -2370000
Owner earnings: -878000
Buffett classification: The Gruesome
Stock price: 1.15
Shares outstanding: 12599879
Book value: 10006000
P/B ratio: 1.4481172146711971
Market cap (USD): 14489860.85
Debt to equity: 0.06885868478912652
Current ratio: 0.6233079526226735
Quick ratio: 0.6233079526226735
Interest coverage ratio: -29.65573770491803
COGS to revenue (%): 32.0614663367626
R&D to revenue (%): 27.086860268264097
SG&A to revenue (%): 45.5593176194817
Free cash flow (dilution-adjusted): -1352000
Buyback yield (%): 0
Retained earnings: -91538000
Receivables turnover: 11.923913043478262
Capitalized R&D asset: 7686540
ROCI (R&D-adjusted, %): -7.189086811770204
Rosenberg metric: -0.1187822777928785
FCF margin (%): -8.803229587185832
Revenue growth (%): -3.3175952156122133
Rule of 40 score: -12.120824802798046
Financial ratios for BLIN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.15
Shares outstanding: 12599879
Market cap (USD): 14489860.85
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLIN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.58
Shares outstanding: 12599879
Market cap (USD): 19907808.82
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLIN — quarterly report dated 2025-03-31
Total revenue: 3875000
Gross profit: 2616000
Operating income: -548000
Net income: -730000
Capital expenditures: 2000
Operating cash flow: -372000
Depreciation & amortization: 202000
Net tangible assets: -1420000
Owner earnings: -530000
Buffett classification: The Gruesome
Stock price: 1.48
Shares outstanding: 12599879
Book value: 10590000
P/B ratio: 1.7608896052880074
Market cap (USD): 18647820.919999998
Debt to equity: 0.05694050991501416
Current ratio: 0.8646575342465753
Quick ratio: 0.8646575342465753
Interest coverage ratio: -109.6
COGS to revenue (%): 32.490322580645156
R&D to revenue (%): 28.64516129032258
SG&A to revenue (%): 47.97419354838709
Free cash flow (dilution-adjusted): -481000
Buyback yield (%): 0
Retained earnings: -92902000
Receivables turnover: 2.767857142857143
Capitalized R&D asset: 1110000
ROCI (R&D-adjusted, %): 1.5173067804646752
FCF margin (%): -12.412903225806451
Rule of 40 score: -12.412903225806451
Financial ratios for BLIN — quarterly report dated 2025-06-30
Total revenue: 3846000
Gross profit: 2548000
Operating income: -679000
Net income: -789000
Capital expenditures: 5000
Operating cash flow: -565000
Depreciation & amortization: 198000
Net tangible assets: -1878000
Owner earnings: -596000
Buffett classification: The Gruesome
Stock price: 1.39
Shares outstanding: 12599879
Book value: 9949000
P/B ratio: 1.7603610222132875
Market cap (USD): 17513831.81
Debt to equity: 0.05166348376721278
Current ratio: 0.7729422894985809
Quick ratio: 0.7729422894985809
COGS to revenue (%): 33.74934997399896
R&D to revenue (%): 24.9869994799792
SG&A to revenue (%): 53.84815392615705
Free cash flow (dilution-adjusted): -844000
Buyback yield (%): 0
Retained earnings: -93691000
Receivables turnover: 2.7451820128479656
Capitalized R&D asset: 1704700
ROCI (R&D-adjusted, %): -3.249069705143609
Rosenberg metric: -0.06126126126126126
FCF margin (%): -21.944877795111807
Revenue growth (%): -0.7483870967741936
Rule of 40 score: -22.693264891886002
Financial ratios for BLIN — quarterly report dated 2025-09-30
Total revenue: 3871000
Gross profit: 2542000
Operating income: -457000
Net income: -34000
Capital expenditures: 6000
Operating cash flow: -345000
Depreciation & amortization: 194000
Net tangible assets: -2076000
Owner earnings: 154000
Buffett classification: The Gruesome
Stock price: 1.32
Shares outstanding: 12599879
Book value: 9568000
P/B ratio: 1.7382776212374582
Market cap (USD): 16631840.280000001
Debt to equity: 0.04807692307692308
Current ratio: 0.6981132075471698
Quick ratio: 0.6981132075471698
COGS to revenue (%): 34.35804701627486
R&D to revenue (%): 22.73314389046758
SG&A to revenue (%): 49.728752260397826
Free cash flow (dilution-adjusted): -445000
Buyback yield (%): 0
Retained earnings: -94056000
Receivables turnover: 2.5103761348897535
Capitalized R&D asset: 1890170
ROCI (R&D-adjusted, %): -4.582792838963874
Rosenberg metric: -0.006243496357960458
FCF margin (%): -11.495737535520538
Revenue growth (%): 0.6500260010400416
Rule of 40 score: -10.845711534480497
Financial ratios for BLIN — annual report dated 2025-09-30
Total revenue: 15383000
Gross profit: 10241000
Operating income: -2185000
Net income: -2518000
Capital expenditures: 18000
Operating cash flow: -1104000
Depreciation & amortization: 794000
Net tangible assets: -2076000
Owner earnings: -1742000
Buffett classification: The Gruesome
Stock price: 1.32
Shares outstanding: 12599879
Book value: 9568000
P/B ratio: 1.7382776212374582
Market cap (USD): 16631840.280000001
Debt to equity: 0.04807692307692308
Current ratio: 0.6981132075471698
Quick ratio: 0.6981132075471698
Interest coverage ratio: -17.341269841269842
COGS to revenue (%): 33.42650978352727
R&D to revenue (%): 26.158746668400184
SG&A to revenue (%): 49.554703243840606
Free cash flow (dilution-adjusted): -1704000
Buyback yield (%): 1.9901586019800326
Retained earnings: -94056000
Receivables turnover: 9.976005188067445
Capitalized R&D asset: 8025270
ROCI (R&D-adjusted, %): -11.515609130538849
Rosenberg metric: -0.04639423076923077
FCF margin (%): -11.077163102125724
Revenue growth (%): 0.1627816121890871
Rule of 40 score: -10.914381489936636
Financial ratios for BLIN — quarterly report dated 2025-12-31
Total revenue: 3913000
Gross profit: 2588000
Operating income: -146000
Net income: -86000
Capital expenditures: 7000
Operating cash flow: -39000
Depreciation & amortization: 190000
Net tangible assets: -1907000
Owner earnings: 97000
Buffett classification: The Gruesome
Stock price: 0.83
Shares outstanding: 12599879
Book value: 9554000
P/B ratio: 1.094609542599958
Market cap (USD): 10457899.57
Debt to equity: 0.07567510990161189
Current ratio: 0.7057585613162426
Quick ratio: 0.7057585613162426
COGS to revenue (%): 33.861487349859445
R&D to revenue (%): 20.240224891387683
SG&A to revenue (%): 44.77383082034245
Free cash flow (dilution-adjusted): -134000
Buyback yield (%): 0
Retained earnings: -94142000
Receivables turnover: 2.461006289308176
Capitalized R&D asset: 1698730
ROCI (R&D-adjusted, %): -1.8977047056796523
Rosenberg metric: 0.05227272727272727
FCF margin (%): -3.4244824942499363
Revenue growth (%): 1.0849909584086799
Rule of 40 score: -2.3394915358412565
Financial ratios for BURL — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 236.93
Shares outstanding: 62942206
Market cap (USD): 14912896867.58
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BURL — annual report dated 2023-01-31
Total revenue: 8702604000
Gross profit: 3530889000
Operating income: 383135000
Net income: 230123000
Capital expenditures: 423142000
Operating cash flow: 596385000
Depreciation & amortization: 270398000
Net tangible assets: 509841000
Owner earnings: 77379000
Return on net tangible assets (%): 15.17708462049933
Capex to operating income (%): 110.44201130149946
Buffett classification: The Gruesome
Stock price: 229.83
P/E ratio: 62.8620659602908
Shares outstanding: 62942206
Book value: 794905000
P/B ratio: 18.198410130745184
Market cap (USD): 14466007204.980001
Debt to equity: 5.915309376592171
Current ratio: 1.1944824945827586
Quick ratio: 0.5762752288107802
Effective tax rate (%): 25.16544231225753
Interest coverage ratio: 5.763682041098775
COGS to revenue (%): 59.42721282043857
SG&A to revenue (%): 33.06316132504708
Free cash flow (dilution-adjusted): 77802000
Buyback yield (%): 2.1906252050732204
Retained earnings: 644415000
Inventory turnover: 4.37546003238628
Receivables turnover: 122.41498923914419
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.1511816943486
FCF margin (%): 0.8940082761435544
Rule of 40 score: 0.8940082761435544
Financial ratios for BURL — annual report dated 2024-01-31
Total revenue: 9727467000
Gross profit: 4143407000
Operating income: 548028000
Net income: 339649000
Capital expenditures: 503745000
Operating cash flow: 868735000
Depreciation & amortization: 307064000
Net tangible assets: 711868000
Owner earnings: 142968000
Return on net tangible assets (%): 20.083498626149794
Capex to operating income (%): 91.91957345245133
Buffett classification: The Gruesome
Stock price: 191.15
P/E ratio: 35.42304754879302
Shares outstanding: 62942206
Book value: 996932000
P/B ratio: 12.068428615893563
Market cap (USD): 12031402676.9
Debt to equity: 4.819620595988493
Current ratio: 1.1470031831844265
Quick ratio: 0.6108002519733476
Effective tax rate (%): 27.078426615540184
Interest coverage ratio: 6.9902422224773275
COGS to revenue (%): 57.40507780699744
SG&A to revenue (%): 33.80443233577662
Free cash flow (dilution-adjusted): 267503000
Buyback yield (%): 2.021277207078399
Retained earnings: 984064000
Inventory turnover: 5.133158246471681
Receivables turnover: 130.81409609876144
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.651687004033423
FCF margin (%): 2.7499759187052497
Revenue growth (%): 11.776509651593937
Rule of 40 score: 14.526485570299187
Financial ratios for BURL — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 247.77
Shares outstanding: 62942206
Market cap (USD): 15595190380.62
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BURL — annual report dated 2025-01-31
Total revenue: 10634823000
Gross profit: 4609551000
Operating income: 715009000
Net income: 503639000
Capital expenditures: 882254000
Operating cash flow: 863376000
Depreciation & amortization: 347575000
Net tangible assets: 1085432000
Owner earnings: -31040000
Return on net tangible assets (%): -2.859690888051946
Capex to operating income (%): 123.39061466359165
Buffett classification: The Gruesome
Stock price: 283.93
P/E ratio: 35.484107762861896
Shares outstanding: 62942206
Book value: 1370496000
P/B ratio: 13.039936307424465
Market cap (USD): 17871180549.58
Debt to equity: 3.9194021726440647
Current ratio: 1.1567833995082972
Quick ratio: 0.606390024074691
Effective tax rate (%): 25.366249070114133
Interest coverage ratio: 10.284643709904778
COGS to revenue (%): 56.656062823048394
SG&A to revenue (%): 33.35238395599062
Free cash flow (dilution-adjusted): -116179000
Buyback yield (%): 1.4341134279795704
Retained earnings: 1487703000
Inventory turnover: 4.817230916831565
Receivables turnover: 120.74186809568683
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.003690114132223
FCF margin (%): -1.0924394322312652
Revenue growth (%): 9.327772584579314
Rule of 40 score: 8.23533315234805
Financial ratios for BURL — quarterly report dated 2025-01-31
Total revenue: 3277057000
Gross profit: 1408774000
Operating income: 352625000
Net income: 260768000
Capital expenditures: 346368000
Operating cash flow: 543164000
Depreciation & amortization: 91481000
Net tangible assets: 1085432000
Owner earnings: 5881000
Return on net tangible assets (%): 0.5418119237317492
Capex to operating income (%): 98.22559376107763
Buffett classification: The Gruesome
Stock price: 283.93
P/E ratio: 17.13321855977344
Shares outstanding: 62942206
Book value: 1370496000
P/B ratio: 13.039936307424465
Market cap (USD): 17871180549.58
Debt to equity: 3.9194021726440647
Current ratio: 1.1567833995082972
Quick ratio: 0.606390024074691
Effective tax rate (%): 24.95236998877601
Interest coverage ratio: 19.03817082388511
COGS to revenue (%): 57.01100102927719
SG&A to revenue (%): 29.437022303853734
Free cash flow (dilution-adjusted): 169276000
Buyback yield (%): 0.34744766764420204
Retained earnings: 1487703000
Inventory turnover: 1.4937003058103975
Receivables turnover: 37.20588335471565
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.426751588435775
FCF margin (%): 5.165488424522369
Rule of 40 score: 5.165488424522369
Financial ratios for BURL — quarterly report dated 2025-04-30
Total revenue: 2504020000
Gross profit: 1098929000
Operating income: 139088000
Net income: 100833000
Capital expenditures: 412683000
Operating cash flow: -28908000
Depreciation & amortization: 91783000
Net tangible assets: 1067133000
Owner earnings: -220067000
Return on net tangible assets (%): -20.622265453322125
Capex to operating income (%): 296.70640170251926
Buffett classification: The Gruesome
Stock price: 225.04
P/E ratio: 35.11874594190394
Shares outstanding: 62942206
Book value: 1352197000
P/B ratio: 10.47518522688632
Market cap (USD): 14164514038.24
Debt to equity: 3.94125486153275
Current ratio: 1.0589327390421603
Quick ratio: 0.38676979887481916
Effective tax rate (%): 24.11267987235836
Interest coverage ratio: 8.797469955724225
COGS to revenue (%): 56.113409637303214
SG&A to revenue (%): 34.66657614555794
Free cash flow (dilution-adjusted): -468829000
Buyback yield (%): 0.9005815494666293
Retained earnings: 1588536000
Inventory turnover: 1.0682535603611603
Receivables turnover: 23.462136686468153
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1096135085156265
FCF margin (%): -18.723053330244966
Revenue growth (%): -23.589366922821302
Rule of 40 score: -42.312420253066264
Financial ratios for BURL — quarterly report dated 2025-07-31
Total revenue: 2705071000
Gross profit: 1185442000
Operating income: 140701000
Net income: 94185000
Capital expenditures: 168731000
Operating cash flow: 179440000
Depreciation & amortization: 94810000
Net tangible assets: 1161753000
Owner earnings: 20264000
Return on net tangible assets (%): 1.7442606130563036
Capex to operating income (%): 119.92167788430785
Buffett classification: The Gruesome
Stock price: 272.96
P/E ratio: 37.6946737059936
Shares outstanding: 62942206
Book value: 1446817000
P/B ratio: 11.87482905561657
Market cap (USD): 17180704549.76
Debt to equity: 4.0355573648913445
Current ratio: 1.22936926937416
Quick ratio: 0.553651409833059
Effective tax rate (%): 26.027300430398036
Interest coverage ratio: 8.073736156538704
COGS to revenue (%): 56.17704673925379
SG&A to revenue (%): 35.116675310925295
Free cash flow (dilution-adjusted): -44086000
Buyback yield (%): 0.15901559753195127
Retained earnings: 1682721000
Inventory turnover: 1.0740839431897056
Receivables turnover: 24.318305224927183
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.949991053942578
FCF margin (%): -1.629753895553943
Revenue growth (%): 8.029129160310221
Rule of 40 score: 6.399375264756278
Financial ratios for BURL — quarterly report dated 2025-10-31
Total revenue: 2710440000
Gross profit: 1200587000
Operating income: 153786000
Net income: 104750000
Capital expenditures: 256350000
Operating cash flow: 143332000
Depreciation & amortization: 99283000
Net tangible assets: 1242445000
Owner earnings: -52317000
Return on net tangible assets (%): -4.210810136464794
Capex to operating income (%): 166.69267683664313
Buffett classification: The Gruesome
Stock price: 273.59
P/E ratio: 30.72123492432243
Shares outstanding: 62942206
Book value: 1527509000
P/B ratio: 11.273490460311525
Market cap (USD): 17220358139.539997
Debt to equity: 3.891797036875069
Current ratio: 1.2082565509378194
Quick ratio: 0.45551598677557514
Effective tax rate (%): 24.126641508340636
Interest coverage ratio: 8.02892346246215
COGS to revenue (%): 55.7050884727203
SG&A to revenue (%): 34.9580879857145
Free cash flow (dilution-adjusted): -140447000
Buyback yield (%): 0.36768108704208025
Retained earnings: 1787471000
Inventory turnover: 0.9104083066264279
Receivables turnover: 23.32102940037686
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.080010041222573
FCF margin (%): -5.181704815454317
Revenue growth (%): 0.19847907873767456
Rule of 40 score: -4.983225736716642
Financial ratios for BURL — quarterly report dated 2026-01-31
Total revenue: 3647379000
Gross profit: 1595030000
Operating income: 411362000
Net income: 310386000
Capital expenditures: 217058000
Operating cash flow: 937518000
Depreciation & amortization: 131995000
Net tangible assets: 1522195000
Owner earnings: 225323000
Return on net tangible assets (%): 14.802505592253294
Capex to operating income (%): 52.76569055965305
Buffett classification: The Good
Stock price: 295.86
P/E ratio: 30.52029662537654
Shares outstanding: 62942206
Book value: 1807259000
P/B ratio: 10.304046662465092
Market cap (USD): 18622081067.16
Debt to equity: 3.3227871600030765
Current ratio: 1.2322240999177045
Quick ratio: 0.648951565682366
Effective tax rate (%): 25.72080868416518
Interest coverage ratio: 22.056943699731903
COGS to revenue (%): 56.26914559742763
SG&A to revenue (%): 28.833663844640217
Free cash flow (dilution-adjusted): 695421000
Buyback yield (%): 0.3233956494057108
Retained earnings: 2097856000
Inventory turnover: 1.564406057460041
Receivables turnover: 34.63929304057134
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.36336713931414
FCF margin (%): 19.06632132279097
Revenue growth (%): 34.56778235268075
Rule of 40 score: 53.63410367547172
Financial ratios for BURL — annual report dated 2026-01-31
Total revenue: 11566910000
Gross profit: 5079988000
Operating income: 844937000
Net income: 610153000
Capital expenditures: 1055050000
Operating cash flow: 1231382000
Depreciation & amortization: 417871000
Net tangible assets: 1522195000
Owner earnings: -27026000
Return on net tangible assets (%): -1.775462407904375
Capex to operating income (%): 124.8672977985341
Buffett classification: The Gruesome
Stock price: 295.86
P/E ratio: 30.52034664610352
Shares outstanding: 62942206
Book value: 1807259000
P/B ratio: 10.304046662465092
Market cap (USD): 18622081067.16
Debt to equity: 3.3227871600030765
Current ratio: 1.2322240999177045
Quick ratio: 0.648951565682366
Effective tax rate (%): 25.23715933235145
Interest coverage ratio: 11.893652960966202
COGS to revenue (%): 56.08171931829676
SG&A to revenue (%): 33.000861941521116
Free cash flow (dilution-adjusted): 42059000
Buyback yield (%): 1.4951175381305617
Retained earnings: 2097856000
Inventory turnover: 4.944665878498639
Receivables turnover: 109.8513713721319
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.0163489592881
FCF margin (%): 0.3636148288523037
Revenue growth (%): 8.764480612418279
Rule of 40 score: 9.128095441270583
Financial ratios for CDP.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.4210526315789473
Shares outstanding: 82737213
Market cap (USD): 200311147.2631579
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDP.AX — annual report dated 2022-06-30
Total revenue: 36357931.03448276
Gross profit: 22329655.172413792
Operating income: 22087586.20689655
Net income: 45874482.758620694
Capital expenditures: 0
Net tangible assets: 363210344.82758623
Owner earnings: 45874482.758620694
Return on net tangible assets (%): 12.630279784678775
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.372413793103448
P/E ratio: 4.278781874379867
Shares outstanding: 82737213
Book value: 363210344.82758623
P/B ratio: 0.5404221221102998
Market cap (USD): 196286905.32413793
Debt to equity: 0.48049292231157015
Current ratio: 0.3427580135673968
Quick ratio: 0.3427580135673968
Effective tax rate (%): 0
Interest coverage ratio: 3.7392877991827205
COGS to revenue (%): 38.583812287789975
Free cash flow (dilution-adjusted): 19373103.448275864
Buyback yield (%): 0
Retained earnings: 209215862.06896552
Receivables turnover: 19.332233223322334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.107558076154052
FCF margin (%): 53.284394620535295
Rule of 40 score: 53.284394620535295
Financial ratios for CDP.AX — annual report dated 2023-06-30
Total revenue: 36355629.13907285
Gross profit: 23033112.582781456
Operating income: 22869536.42384106
Net income: 5313907.284768212
Capital expenditures: 0
Net tangible assets: 349949006.6225166
Owner earnings: 5313907.284768212
Return on net tangible assets (%): 1.518480459783166
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.2649006622516556
P/E ratio: 35.264365461116654
Shares outstanding: 82737213
Book value: 349949006.6225166
P/B ratio: 0.5354824987935801
Market cap (USD): 187391568.5165563
Debt to equity: 0.4552205335498265
Current ratio: 0.45695162762397323
Quick ratio: 0.45695162762397323
Effective tax rate (%): 0
Interest coverage ratio: 3.7894217052562276
COGS to revenue (%): 36.64498970799861
Free cash flow (dilution-adjusted): 18411920.529801324
Buyback yield (%): 0
Retained earnings: 188745033.11258277
Receivables turnover: 34.657196969696976
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.490800705357282
FCF margin (%): 50.64393318396269
Revenue growth (%): -0.006331205721603619
Rule of 40 score: 50.637601978241086
Financial ratios for CDP.AX — annual report dated 2024-06-30
Total revenue: 38579333.333333336
Gross profit: 24229333.333333332
Operating income: 24066000
Net income: 5082666.666666667
Capital expenditures: 0
Net tangible assets: 353120000
Owner earnings: 5082666.666666667
Return on net tangible assets (%): 1.4393596133514577
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.52
P/E ratio: 41.021335931269675
Shares outstanding: 82737213
Book value: 353120000
P/B ratio: 0.5904445422519258
Market cap (USD): 208497776.76
Debt to equity: 0.4251472587222474
Current ratio: 0.34385648426538384
Quick ratio: 0.34385648426538384
Effective tax rate (%): 0
Interest coverage ratio: 3.711597779148674
COGS to revenue (%): 37.19608080319342
Free cash flow (dilution-adjusted): 17624666.666666668
Buyback yield (%): 0
Retained earnings: 176730000
Receivables turnover: 31.399348887683125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.7821352494197695
FCF margin (%): 45.68421780227756
Revenue growth (%): 6.116533386766732
Rule of 40 score: 51.80075118904429
Financial ratios for CHEMPLASTS.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.771594355795859
Shares outstanding: 158109574
Market cap (USD): 1386873046.8956876
Buyback yield (%): 0
Retained earnings: 217639456.67941448
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHEMPLASTS.NS — annual report dated 2023-03-31
Total revenue: 601038976.8574909
Gross profit: 197666260.65773448
Operating income: 47912302.070645556
Net income: 18556638.246041413
Capital expenditures: 51103532.27771011
Operating cash flow: 43292326.43118149
Depreciation & amortization: 17295980.511571255
Net tangible assets: 226365408.03897688
Owner earnings: -15250913.520097442
Return on net tangible assets (%): -6.737298623591576
Capex to operating income (%): 106.66056538539759
Buffett classification: The Gruesome
Stock price: 4.236906211936663
P/E ratio: 36.10004287226781
Shares outstanding: 158109574
Book value: 226365408.0389769
P/B ratio: 2.959354267291198
Market cap (USD): 669895436.2472595
Debt to equity: 0.5484164308083035
Current ratio: 0.9603061292993489
Quick ratio: 0.6724819298677468
Effective tax rate (%): 11.17136027053816
Interest coverage ratio: 5.443675615831719
COGS to revenue (%): 67.11257201800375
SG&A to revenue (%): 2.3432829469067977
Free cash flow (dilution-adjusted): -7814859.926918393
Buyback yield (%): 0
Retained earnings: 224930572.4725944
Inventory turnover: 5.149572383766133
Receivables turnover: 34.5942933258553
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.919326452773412
FCF margin (%): -1.3002251480890785
Rule of 40 score: -1.3002251480890785
Financial ratios for CHEMPLASTS.NS — annual report dated 2024-03-31
Total revenue: 469599472.358796
Gross profit: 133115481.47259863
Operating income: -10828636.52716153
Net income: -18998680.896990046
Capital expenditures: 70492864.85190071
Operating cash flow: -29371627.29344046
Depreciation & amortization: 18150857.41695647
Net tangible assets: 203930926.96966064
Owner earnings: -71340688.33193429
Return on net tangible assets (%): -34.98277058415364
Buffett classification: The Gruesome
Stock price: 5.3982725527831095
Shares outstanding: 158109574
Book value: 203930926.96966064
P/B ratio: 4.185331701961077
Market cap (USD): 853518573.65643
Debt to equity: 0.9099895329828646
Current ratio: 0.741272538392778
Quick ratio: 0.5123130692479283
Interest coverage ratio: -1.0412822878228782
COGS to revenue (%): 71.65340054494521
SG&A to revenue (%): 2.0835088955794068
Free cash flow (dilution-adjusted): -103593956.10984531
Buyback yield (%): 0
Retained earnings: 207925410.72070992
Inventory turnover: 4.934562017480611
Receivables turnover: 20.60505130228887
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.5459856319570537
FCF margin (%): -22.060066547667386
Revenue growth (%): -21.86871560076208
Rule of 40 score: -43.92878214842946
Financial ratios for CHEMPLASTS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 207695891.06545627
Buffett classification: The Gruesome
Stock price: 6.142498805542284
Shares outstanding: 158109574
Book value: 207695891.06545633
P/B ratio: 4.6760090652622734
Market cap (USD): 971187869.4397994
Debt to equity: 0.8770265063289681
Current ratio: 0.7080068823547485
Quick ratio: 0.42657541401665283
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHEMPLASTS.NS — annual report dated 2025-03-31
Total revenue: 506001870.46995556
Gross profit: 172122983.39957914
Operating income: 6195931.727846621
Net income: -12901566.518587794
Capital expenditures: 42042319.38274491
Operating cash flow: 20068973.579611875
Depreciation & amortization: 23253448.678980593
Net tangible assets: 241033434.65045592
Owner earnings: -31690437.22235211
Return on net tangible assets (%): -13.147734988844698
Capex to operating income (%): 678.5471698113207
Buffett classification: The Gruesome
Stock price: 5.077021822849808
Shares outstanding: 158109574
Book value: 241808510.6382978
P/B ratio: 3.3196753723867913
Market cap (USD): 802725757.5994866
Debt to equity: 0.8903951306063055
Current ratio: 0.6538764715416009
Quick ratio: 0.411766439274506
Interest coverage ratio: 0.4132231404958677
COGS to revenue (%): 65.98372586257086
SG&A to revenue (%): 1.9691151804155866
Free cash flow (dilution-adjusted): -24615384.615384612
Buyback yield (%): 0
Retained earnings: 197464344.1664718
Inventory turnover: 4.345114028815287
Receivables turnover: 27.847519783825515
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3990259611704305
FCF margin (%): -4.864682534181695
Revenue growth (%): 7.751797064061951
Rule of 40 score: 2.8871145298802565
Financial ratios for CHEMPLASTS.NS — quarterly report dated 2025-03-31
Total revenue: 134542903.904606
Gross profit: 45570493.33645078
Operating income: -2936637.8302548514
Net income: -6332709.843348141
Capital expenditures: 0
Depreciation & amortization: 7230535.422024783
Net tangible assets: 241033434.65045592
Owner earnings: 897825.5786766419
Buffett classification: The Gruesome
Stock price: 5.077021822849808
Shares outstanding: 158109574
Book value: 241808510.6382978
P/B ratio: 3.3196753723867913
Market cap (USD): 802725757.5994866
Debt to equity: 0.8903951306063055
Current ratio: 0.6538764715416009
Quick ratio: 0.411766439274506
Interest coverage ratio: -0.40739539409665915
COGS to revenue (%): 66.12939663561797
Buyback yield (%): 0
Retained earnings: 197464344.1664718
Inventory turnover: 1.1578907331619226
Receivables turnover: 7.404490767548091
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6630855121622872
Rule of 40 score: 0
Financial ratios for CHEMPLASTS.NS — quarterly report dated 2025-06-30
Total revenue: 128703487.01146737
Gross profit: 42968640.299555354
Operating income: -4237069.974256963
Net income: -7518137.140182542
Capital expenditures: 0
Depreciation & amortization: 6234495.670489118
Owner earnings: -1283641.4696934232
Buffett classification: The Gruesome
Stock price: 5.137491223964428
Shares outstanding: 158109574
Market cap (USD): 812286548.8497543
Interest coverage ratio: -0.6116554054054054
COGS to revenue (%): 66.6142376579689
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -4.340189429298276
Rule of 40 score: -4.340189429298276
Financial ratios for CHEMPLASTS.NS — quarterly report dated 2025-09-30
Total revenue: 116482525.36640361
Gross profit: 43898534.385569334
Operating income: -997745.2085682075
Net income: -5754227.733934611
Capital expenditures: 0
Depreciation & amortization: 5873731.6798196165
Net tangible assets: 219535512.96505073
Owner earnings: 119503.9458850054
Buffett classification: The Gruesome
Stock price: 4.384441939120631
Shares outstanding: 158109574
Book value: 220154453.21307778
P/B ratio: 3.1487995682338417
Market cap (USD): 693222247.2220969
Debt to equity: 0.9672772523133805
Current ratio: 0.586259176222811
Quick ratio: 0.3380997843833471
Interest coverage ratio: -0.14669318746892093
COGS to revenue (%): 62.31320170344561
Buyback yield (%): 0
Inventory turnover: 0.9276811573320269
Receivables turnover: 13.920776071139855
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.24070694405535445
Revenue growth (%): -9.49543942346712
Rule of 40 score: -9.49543942346712
Financial ratios for CHEMPLASTS.NS — quarterly report dated 2025-12-31
Total revenue: 93031079.42519774
Gross profit: 29249192.380528018
Operating income: -12245739.111061603
Net income: -13278378.077308679
Capital expenditures: 0
Depreciation & amortization: 5924028.0717388885
Owner earnings: -7354350.0055697905
Buffett classification: The Gruesome
Stock price: 2.909658014927036
Shares outstanding: 158109574
Market cap (USD): 460044789.22579926
Interest coverage ratio: -1.8875343406593408
COGS to revenue (%): 68.55976243504082
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -20.13301640519707
Rule of 40 score: -20.13301640519707
Financial ratios for CIG — annual report dated 2021-12-31
Operating income: 1247935368.043088
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.84
Shares outstanding: 1904080104
Market cap (USD): 1599427287.36
Buyback yield (%): 0
Retained earnings: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIG — annual report dated 2022-12-31
Total revenue: 8275757575.757575
Gross profit: 786742424.2424242
Operating income: 665909090.9090909
Net income: 775378787.8787879
Capital expenditures: 32765151.515151512
Operating cash flow: 1239393939.3939393
Depreciation & amortization: 223863636.36363634
Net tangible assets: 1355492424.2424242
Owner earnings: 966477272.7272727
Return on net tangible assets (%): 71.30082436775184
Capex to operating income (%): 4.920364050056882
Buffett classification: The Great
Stock price: 1.03
P/E ratio: 2.5293476398616512
Shares outstanding: 1904080104
Book value: 4125757575.757575
P/B ratio: 0.4753557307011385
Market cap (USD): 1961202507.1200001
Debt to equity: 0.5019739258171135
Current ratio: 1.2019102026242972
Quick ratio: 1.2019102026242972
Effective tax rate (%): 0.6310679611650485
Interest coverage ratio: 3.788793103448276
COGS to revenue (%): 63.280391797876234
SG&A to revenue (%): 3.233705602343464
Free cash flow (dilution-adjusted): 1184090909.090909
Buyback yield (%): 0
Retained earnings: 0
Receivables turnover: 5.24247150569886
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.27917490816615
FCF margin (%): 14.307945807396557
Rule of 40 score: 14.307945807396557